SCHEDULE 13G/A: Thomas J. Coleman Amends Forian Inc. Stake, Reports 2.9% Beneficial Ownership
Beneficial Ownership Amendment
Thomas J. Coleman has filed an Amendment No. 1 to Schedule 13G, disclosing a beneficial ownership of 2.9% of Forian Inc.'s common stock as of December 31, 2024.
Summary
- Thomas J. Coleman filed an Amendment No. 1 to his Schedule 13G regarding Forian Inc. common stock.
- As of December 31, 2024, Mr. Coleman beneficially owns 908,478 shares of Forian Inc. common stock.
- This represents 2.9% of the total class of securities, indicating his stake is now below the 5% threshold.
- Mr. Coleman holds sole voting power and sole dispositive power over all 908,478 shares.
- The percentage ownership is calculated based on 31,016,379 shares of Common Stock outstanding as of November 12, 2024, as reported in Forian Inc.'s Form 10-Q for the period ended September 30, 2024.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: Neutral. This is a factual disclosure of a shareholder's stake. While the reduction below 5% could be seen as slightly negative, the filing itself is a routine regulatory update for a Schedule 13G/A.
Positives
- The filing explicitly states that the securities are not held for the purpose of changing or influencing control of the issuer, indicating a passive investment stance from Thomas J. Coleman.
Negatives
- The filing indicates that Thomas J. Coleman's beneficial ownership in Forian Inc. has fallen below the 5% threshold, as stated in Item 5, suggesting a reduction from a previously larger stake that would have triggered the initial Schedule 13G filing.
Risks
- The reduction in beneficial ownership by a significant individual shareholder, as indicated by the filing falling below the 5% threshold, could be perceived by the market as a negative signal regarding the investor's confidence in Forian Inc.'s future prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an individual investor in Forian Inc., a company operating in the healthcare data and analytics sector. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual shareholder's stake in Forian Inc. The reduction in stake below 5% might be interpreted by other shareholders as a signal, though the filing states it's not for control purposes.
Key Dates
| Date | Description |
|---|---|
| 2022-02-14 | Original Schedule 13G filed by Thomas J. Coleman with the SEC. |
| 2024-09-30 | End of the period for Forian Inc.'s Form 10-Q, which reported shares outstanding. |
| 2024-11-12 | Date as of which 31,016,379 shares of Common Stock were outstanding, as reported in Forian Inc.'s Form 10-Q. |
| 2024-11-13 | Date Forian Inc.'s Report on Form 10-Q for the period ended September 30, 2024, was filed with the SEC. |
| 2024-12-31 | Date of event which requires filing of this statement (beneficial ownership snapshot date). |
| 2025-02-13 | Date the Amendment No. 1 to Schedule 13G was signed by Thomas J. Coleman. |
Keywords
Forian Inc., Thomas J. Coleman, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Shareholder, Investment Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.